Pharmaceutical Strategies Group - PSG

psgconsults.com

Pharmaceutical Strategies Group (PSG) is the largest independent pharmacy benefit consulting firm in the U.S. We provide strategic advisory, consulting, analytics, clinical, and administrative solutions to hospitals and health systems, health plans, self-funded employers, Taft-Hartley Funds, and other healthcare purchasers. PSG’s unique approach and expert staff use PSG’s proprietary intellectual property and technology resources to reduce costs, enhance revenue, and optimize health outcomes associated with prescription drug and patient/population management programs.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharmacy Market

EAGLE PHARMACEUTICALS AGREED TO ACQUIRE ACACIA PHARMA GROUP PLC

Eagle Pharmaceuticals, Inc. | March 29, 2022

news image

Eagle Pharmaceuticals, Inc. reported that it had achieved an agreement with Acacia Pharma Group plc on the parameters of a plan of arrangement under Part 26 of the United Kingdom's Companies Act 2006. Acacia Pharma's current issued and to be issued, share capital is valued at approximately €94,700,000, or the equivalent of €0.90 per share, under the terms of the proposed transaction. Each Acacia Pharma shareholder would get €0.68 in cash and 0.0049 shares of...

Read More

Pharma Tech

MODERNA HITCHES A RIDE WITH UBER TO BOOST VACCINE CONFIDENCE—AND, OF COURSE, DRIVE ACCESS

Moderna | January 15, 2021

news image

COVID-19 vaccine maker Moderna is looking for a lift from Uber—a collaboration lift, that is. The two companies say they're planning to work together to promote vaccine confidence and ease access to coronavirus shots. Early ideas include promoting vaccine safety on the Uber network and through in-app messages as well as incorporating Uber rides into the vaccination scheduling process. While those details are still in the works, the appeal of Uber as a part...

Read More

Business Insights

AQUESTIVE THERAPEUTICS RECEIVES FDA TENTATIVE APPROVAL FOR LIBERVANT™ (DIAZEPAM) BUCCAL FILM

Aquestive Therapeutics, Inc. | August 31, 2022

news image

Aquestive Therapeutics, Inc. a pharmaceutical company advancing medicines to solve patients' problems with current standards of care and provide transformative products to improve their lives, announced today that the U.S. Food & Drug Administration has granted tentative approval for Libervant™ Buccal Film for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity that are distinct from a patient’s usual seizure pattern in patients with epileps...

Read More

Pharmacy Market

REALM IDX LAUNCHES REALM PHARMA SERVICES TO IMPROVE DRUG DEVELOPMENT AND RESEARCH

Businesswire | June 02, 2023

news image

REALM IDx announced the launch of REALM Pharma Services, an end-to-end discovery, translational research, and clinical trial service for biotechnology and pharmaceutical partners. Through a strategic integration, REALM Pharma Services brings together the research arms of subsidiaries, Ambry Genetics and Invicro, to offer cutting-edge genomics, traditional and molecular pathology, and advanced imaging and spatial biology. Combined with machine learning and artificial intelligence (AI) from ...

Read More
news image

Pharmacy Market

EAGLE PHARMACEUTICALS AGREED TO ACQUIRE ACACIA PHARMA GROUP PLC

Eagle Pharmaceuticals, Inc. | March 29, 2022

Eagle Pharmaceuticals, Inc. reported that it had achieved an agreement with Acacia Pharma Group plc on the parameters of a plan of arrangement under Part 26 of the United Kingdom's Companies Act 2006. Acacia Pharma's current issued and to be issued, share capital is valued at approximately €94,700,000, or the equivalent of €0.90 per share, under the terms of the proposed transaction. Each Acacia Pharma shareholder would get €0.68 in cash and 0.0049 shares of...

Read More
news image

Pharma Tech

MODERNA HITCHES A RIDE WITH UBER TO BOOST VACCINE CONFIDENCE—AND, OF COURSE, DRIVE ACCESS

Moderna | January 15, 2021

COVID-19 vaccine maker Moderna is looking for a lift from Uber—a collaboration lift, that is. The two companies say they're planning to work together to promote vaccine confidence and ease access to coronavirus shots. Early ideas include promoting vaccine safety on the Uber network and through in-app messages as well as incorporating Uber rides into the vaccination scheduling process. While those details are still in the works, the appeal of Uber as a part...

Read More
news image

Business Insights

AQUESTIVE THERAPEUTICS RECEIVES FDA TENTATIVE APPROVAL FOR LIBERVANT™ (DIAZEPAM) BUCCAL FILM

Aquestive Therapeutics, Inc. | August 31, 2022

Aquestive Therapeutics, Inc. a pharmaceutical company advancing medicines to solve patients' problems with current standards of care and provide transformative products to improve their lives, announced today that the U.S. Food & Drug Administration has granted tentative approval for Libervant™ Buccal Film for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity that are distinct from a patient’s usual seizure pattern in patients with epileps...

Read More
news image

Pharmacy Market

REALM IDX LAUNCHES REALM PHARMA SERVICES TO IMPROVE DRUG DEVELOPMENT AND RESEARCH

Businesswire | June 02, 2023

REALM IDx announced the launch of REALM Pharma Services, an end-to-end discovery, translational research, and clinical trial service for biotechnology and pharmaceutical partners. Through a strategic integration, REALM Pharma Services brings together the research arms of subsidiaries, Ambry Genetics and Invicro, to offer cutting-edge genomics, traditional and molecular pathology, and advanced imaging and spatial biology. Combined with machine learning and artificial intelligence (AI) from ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us